Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorne Zinman

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 23, 2010
Non-invasive ventilation for Canadian patients with ALS: do we have consensus?Lorne Zinman
The Lancet. Neurology|April 23, 2011
Emerging targets and treatments in amyotrophic lateral sclerosisLorne Zinman, Merit Cudkowicz
Expert Review of Pharmacoeconomics & Outcomes Research|May 1, 2015
The economic impact of amyotrophic lateral sclerosis: a systematic reviewMatthew Gladman, Lorne Zinman
Annals of the New York Academy of Sciences|June 24, 2008
IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategiesLorne Zinman, Vera Bril
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 4, 2024
Rethinking Drug Reimbursement Criteria in Amyotrophic Lateral SclerosisLorne Zinman, Emili Duni, Agessandro Abrahao
Muscle & Nerve|October 9, 2007
Surrogate therapeutic outcome measures in patients with myasthenia gravisLorne Zinman, Devra Baryshnik, Vera Bril
Muscle & Nerve|February 7, 2026
Value of Clinical Evidence and Health Economics and Outcomes Research (HEOR) StudiesAgessandro Abrahao, Malgorzata Ciepielewska, Lorne Zinman
Muscle & Nerve|February 7, 2026
Current and Ongoing Clinical StudiesAgessandro Abrahao, Lorne Zinman, Stephen Apple
Neurology|March 14, 2007
IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trialLorne Zinman, Eduardo Ng, Vera Bril
Current Opinion in Neurology|November 20, 2012
Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosisMatthew Gladman, Merit Cudkowicz, Lorne Zinman
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 23, 2010
Non-invasive ventilation for Canadian patients with ALS: do we have consensus?Lorne Zinman
The Lancet. Neurology|April 23, 2011
Emerging targets and treatments in amyotrophic lateral sclerosisLorne Zinman, Merit Cudkowicz
Expert Review of Pharmacoeconomics & Outcomes Research|May 1, 2015
The economic impact of amyotrophic lateral sclerosis: a systematic reviewMatthew Gladman, Lorne Zinman
Annals of the New York Academy of Sciences|June 24, 2008
IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategiesLorne Zinman, Vera Bril
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 4, 2024
Rethinking Drug Reimbursement Criteria in Amyotrophic Lateral SclerosisLorne Zinman, Emili Duni, Agessandro Abrahao
Muscle & Nerve|October 9, 2007
Surrogate therapeutic outcome measures in patients with myasthenia gravisLorne Zinman, Devra Baryshnik, Vera Bril
Muscle & Nerve|February 7, 2026
Value of Clinical Evidence and Health Economics and Outcomes Research (HEOR) StudiesAgessandro Abrahao, Malgorzata Ciepielewska, Lorne Zinman
Muscle & Nerve|February 7, 2026
Current and Ongoing Clinical StudiesAgessandro Abrahao, Lorne Zinman, Stephen Apple
Neurology|March 14, 2007
IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trialLorne Zinman, Eduardo Ng, Vera Bril
Current Opinion in Neurology|November 20, 2012
Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosisMatthew Gladman, Merit Cudkowicz, Lorne Zinman
Pageof 18